The goal of this clinical research study is to learn if the combination of external beam radiation therapy (EBRT) and pembrolizumab can help control relapsed (has come back) and refractory (has not responded to treatment) non-Hodgkin's Lymphoma (NHL). The safety of this combination will also be studied.